Search - tctmd.com

Displaying 1 - 20 of 62

Sort: Relevancy | Date

News CV Team Pro

NorthShore University Health System

L.A. McKeown

December 30, 2020

News Daily News

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

Caitlin E. Cox

December 23, 2020

News Daily News

Echo Features Pinpoint Those Unlikely to Benefit From MitraClip

Shelley Wood

December 15, 2020

News Daily News

Stay Vigilant for Mechanical Complications of Acute MI, Review Urges

Shelley Wood

December 11, 2020

News Daily News

CAD Common in MitraClip Patients, but When and If to Fix Are Unclear

Shelley Wood

December 03, 2020

Next-Gen MitraClip Performs as Well as Earlier Device in COAPT: EXPAND

Michael O'Riordan

November 25, 2020

News Conference News PCR London Valves 2020

CUTTING-EDGE Insights into MV Surgery Outcomes After Failed Clip Procedures

Shelley Wood

November 24, 2020

News Conference News AHA 2020

Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib

Todd Neale

November 14, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2020

Shelley Wood

October 30, 2020

News Conference News TCT 2020

MitraClip Viable in MI Patients With Acute MR, Including Patients in Shock: IREMMI

Michael O'Riordan

October 17, 2020

Presentation TCT 2020

IREMMI: Outcomes of MitraClip in Patients With Acute Mitral Regurgitation in AMI With and Without Cardiogenic Shock. IREMMI (International REgistry MitraClip in acute Myocardial Infarction)

Presenter: Rodrigo Estévez-Loureiro

October 17, 2020

Presentation TCT 2020

Core-Lab Adjudicated Contemporary Clinical Outcomes at 1 Year with MitraClip™ (NTR/XTR) System from Global EXPAND Study

Presenter: Saibal Kar

October 16, 2020

News Conference News TCT 2020

Global EXPAND: Next-Gen MitraClip Cuts MR, Boosts QoL at 1 Year

L.A. McKeown

October 16, 2020

Presentation TCT 2020

MitraBridge: Outcomes of MitraClip Treatment as Bridge Therapy to Heart Transplantation

Presenter: Cosmo Godino

October 16, 2020

Presentation TCT 2020

Closure of Iatrogenic Atrial Septal Defects Following Transcatheter Mitral Valve Repair – The Randomized MITHRAS Trial

Presenter: Philipp Lurz

October 15, 2020

News Daily News

As Interventions Dip During COVID-19, CMS Offers Leniency on Volumes

Todd Neale

September 23, 2020

News Daily News

In MITRA-FR, ‘Disproportionate’ MR Theory Doesn’t Pan Out

Shelley Wood

September 18, 2020

News Conference News ESC 2020

Implantation Technique Influences LV Remodeling After TMVR

Todd Neale

September 04, 2020

News Industry News

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

September 02, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2020

Caitlin E. Cox

August 28, 2020

Advertisement

NorthShore University Health System

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

Echo Features Pinpoint Those Unlikely to Benefit From MitraClip

Stay Vigilant for Mechanical Complications of Acute MI, Review Urges

CAD Common in MitraClip Patients, but When and If to Fix Are Unclear

Next-Gen MitraClip Performs as Well as Earlier Device in COAPT: EXPAND

CUTTING-EDGE Insights into MV Surgery Outcomes After Failed Clip Procedures

Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib

TCTMD’s Top 10 Most Popular Stories for October 2020

MitraClip Viable in MI Patients With Acute MR, Including Patients in Shock: IREMMI

IREMMI: Outcomes of MitraClip in Patients With Acute Mitral Regurgitation in AMI With and Without Cardiogenic Shock. IREMMI (International REgistry MitraClip in acute Myocardial Infarction)

Core-Lab Adjudicated Contemporary Clinical Outcomes at 1 Year with MitraClip™ (NTR/XTR) System from Global EXPAND Study

Global EXPAND: Next-Gen MitraClip Cuts MR, Boosts QoL at 1 Year

MitraBridge: Outcomes of MitraClip Treatment as Bridge Therapy to Heart Transplantation

Closure of Iatrogenic Atrial Septal Defects Following Transcatheter Mitral Valve Repair – The Randomized MITHRAS Trial

As Interventions Dip During COVID-19, CMS Offers Leniency on Volumes

In MITRA-FR, ‘Disproportionate’ MR Theory Doesn’t Pan Out

Implantation Technique Influences LV Remodeling After TMVR

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

TCTMD’s Top 10 Most Popular Stories for August 2020

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content